• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q180V
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Unspecified Infection (1930)
Event Type  Death  
Manufacturer Narrative
The subject device has not been returned to olympus medical systems corp.(omsc) for evaluation but returned to (b)(4) on january 16,2017.The subject device is under evaluation by (b)(4).Omsc reviewed the manufacture history of the subject device and confirmed no irregularity.The exact cause could not be determined at present, if significant additional information is received, this report will be supplemented.
 
Event Description
Olympus (b)(4) was informed that five patients tested positive for oxa48 producing klebsiella pneumonia after having undergone endoscopic retrograde cholangiography (ercp) using the subject device between (b)(6) 2016 at the facility.The facility reported that four patients are doing well except for one patient ((b)(6)) who deceased of the patient¿s pathology.There was no other detailed information on the cause of the death of the one patient at present.The subject device was reprocessed using non-olympus automated endoscope reprocessor (solscope series 4) and the forceps elevator was replaced according to an olympus field corrective action on october 5,2016.The facility conducted additional microbiological test for the subject device on january 3, 2017 and confirmed the result cleared the criteria of french guideline of (b)(6) 2007 (elements of quality assurance in health related to the microbiological of endoscopes control and traceability in endoscopy).The routine microbiological test of the subject device, which was conducted by the facility before the procedure for the patients, reportedly cleared the guideline this is one of five report.
 
Manufacturer Narrative
This supplemental report is being submitted to provide the device evaluation result.Olympus followed up the facility to obtain additional information and was informed that the facility confirmed that the death of the patient was not attributed by the infection but due to her pre-existing pathology.The subject device has not been returned to olympus medical systems corp.But was returned to olympus (b)(4).Following additional high level disinfection at (b)(4), the subject device was send to a third party laboratory for additional microbiological testing.In the additional test, the testing result obtained for the subject device was defined as target level according to the statement by (b)(6).This is one of five reports.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information.Olympus followed up the facility to obtain additional information on the reprocessing practice at the user facility and was informed that the facility had cleaned the distal end of the subject device with olympus brush (maj-1888) and had cleaned the instrument channel with non-olympus brush (kit 1-clean 1.8mm, prince medical).Except for the use of non-olympus brush, there was no deviation from the instructions of olympus reprocessing manual.Olympus provided reprocessing training for the user facility.This is one of five reports.
 
Manufacturer Narrative
The date received by manufacturer in the follow up number 2 was not (b)(6) 2016 but (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to
Manufacturer Contact
hiroki moriyama
2951 ishikawa-cho
hachioji-shi, tokyo-to 
8142642517
MDR Report Key6295617
MDR Text Key66314721
Report Number8010047-2017-00106
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK143153
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 07/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-Q180V
Other Device ID Number04953170229503
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/16/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/04/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-